Seoul, South Korea

Sang Ki Rhee

This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignees: Dongkook Pharmaceutical Co., Ltd., Korea Research Institute of Bioscience and Biotechnology, Bioland Ltd.. Active years: 1995-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang Ki Rhee. Retrieved from https://idiyas.com/inventor/sang-ki-rhee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3


Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Inventor Sang Ki Rhee: Pioneering Human-Type Glycoprotein Production

Introduction: Sang Ki Rhee, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of biotechnology, specifically in the production of human-type glycoproteins. With a total of nine patents to his name, his work demonstrates a commitment to advancing science and improving health outcomes through innovative processes.

Latest Patents: Among Rhee's latest inventions are two notable patents. The first relates to a process for producing a human-type glycoprotein with reduced glycosylation by genetically manipulating an enzyme involved in glycosylation. This process involves identifying a dolichyl-phosphate-mannose dependent α-1,3-mannosyltransferase gene and creating a mutant strain capable of producing glycoproteins with altered glycosylation profiles. The second patent focuses on a novel gene regulating the Unfolded Protein Response (UPR), offering a method to enhance the efficiency of secretory expression of recombinant proteins. By optimizing the HpHAC1 gene, Rhee's invention enables mass production of secretory proteins, reducing costs and benefiting both industrial and medical applications.

Career Highlights: Sang Ki Rhee's career includes stints at prominent research institutions and companies, such as the Korea Research Institute of Bioscience and Biotechnology and Dongkook Pharmaceutical Co., Ltd. His work has greatly influenced the biopharmaceutical industry, leading to advancements that promote more efficient production methods for therapeutic proteins.

Collaborations: Collaboration has been integral to Rhee's success. He has worked alongside esteemed colleagues, including Hyun Ah Kang and Myung K Kim. Together, they have contributed to various research projects that push the boundaries of biotechnology and improve the methods for producing essential medicinal compounds.

Conclusion: Sang Ki Rhee stands out as a visionary inventor in biotechnology, with a focus on enhancing the efficiency of protein production. His nine patents reflect his dedication to innovation and his impact on the industry. As scientific research continues to evolve, Rhee's contributions will foster advancements that benefit healthcare and society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…